Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $67,850 | 26 | 78.0% |
| Travel and Lodging | $13,586 | 9 | 15.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,450 | 1 | 5.1% |
| Food and Beverage | $1,136 | 25 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $25,143 | 20 | $0 (2020) |
| SANOFI US SERVICES INC. | $22,046 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $15,587 | 19 | $0 (2020) |
| Astellas Pharma Inc | $13,282 | 7 | $0 (2017) |
| Janssen Research & Development, LLC | $6,045 | 4 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $3,686 | 1 | $0 (2018) |
| Regeneron Pharmaceuticals, Inc. | $1,074 | 2 | $0 (2023) |
| Gilead Sciences, Inc. | $87.55 | 3 | $0 (2018) |
| PFIZER INC. | $72.18 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,074 | 2 | Regeneron Pharmaceuticals, Inc. ($1,074) |
| 2020 | $15,065 | 13 | Janssen Pharmaceuticals, Inc ($5,611) |
| 2019 | $18,542 | 5 | SANOFI US SERVICES INC. ($12,742) |
| 2018 | $23,867 | 19 | Janssen Scientific Affairs, LLC ($11,377) |
| 2017 | $28,474 | 22 | Astellas Pharma Inc ($13,282) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/22/2023 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $716.00 | General |
| 09/22/2023 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $358.00 | General |
| 12/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $101.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $58.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/14/2020 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 03/25/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $709.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2020 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2020 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $1,213.50 | General |
| 03/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $4,640.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/25/2020 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $3,640.50 | General |
| 02/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $37.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/17/2020 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/11/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2019 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $12,741.75 | General |
| 08/12/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2019 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $1,900.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/17/2018 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,685.50 | General |
| 11/26/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $3,800.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $486.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2018 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $109.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,102 | 1,187 | $1.1M | $40,527 |
| 2022 | 17 | 997 | 1,050 | $959,807 | $34,078 |
| 2021 | 17 | 985 | 1,026 | $803,851 | $34,383 |
| 2020 | 20 | 1,013 | 1,097 | $521,366 | $31,790 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 103 | $17,976 | $8,819 | 49.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 234 | 243 | $62,650 | $7,842 | 12.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 136 | 142 | $39,521 | $4,141 | 10.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $4,572 | $2,667 | 58.3% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2023 | 54 | 56 | $34,117 | $2,548 | 7.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 64 | 66 | $30,064 | $2,194 | 7.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 100 | 113 | $26,990 | $2,005 | 7.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 14 | $3,142 | $1,729 | 55.0% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 160 | 162 | $466,845 | $1,671 | 0.4% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Facility | 2023 | 67 | 75 | $21,528 | $1,507 | 7.0% |
| 93923 | Complete ultrasound study of arm and leg arteries | Facility | 2023 | 77 | 80 | $373,430 | $1,433 | 0.4% |
| 93930 | Ultrasound of arm arteries or artery grafts | Facility | 2023 | 37 | 37 | $19,738 | $1,224 | 6.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 13 | 13 | $19,180 | $1,057 | 5.5% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Facility | 2023 | 28 | 29 | $11,545 | $969.76 | 8.4% |
| 93990 | Ultrasound of hemodialysis access | Facility | 2023 | 18 | 20 | $14,814 | $389.98 | 2.6% |
| 93931 | Ultrasound of one arm arteries or artery grafts | Facility | 2023 | 16 | 16 | $3,362 | $331.84 | 9.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 213 | 217 | $49,696 | $7,022 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 59 | 77 | $9,900 | $5,850 | 59.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2022 | 94 | 94 | $23,676 | $2,849 | 12.0% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2022 | 122 | 132 | $25,772 | $2,535 | 9.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 15 | 15 | $4,560 | $2,521 | 55.3% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Facility | 2022 | 52 | 52 | $26,263 | $2,382 | 9.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 14 | $5,264 | $1,704 | 32.4% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2022 | 151 | 153 | $437,580 | $1,499 | 0.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2022 | 46 | 46 | $17,330 | $1,487 | 8.6% |
About Dr. Nicholas Leeper, MD
Dr. Nicholas Leeper, MD is a Cardiovascular Disease healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407044639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Leeper, MD has received a total of $87,022 in payments from pharmaceutical and medical device companies, with $1,074 received in 2023. These payments were reported across 61 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($67,850).
As a Medicare-enrolled provider, Leeper has provided services to 4,097 Medicare beneficiaries, totaling 4,360 services with total Medicare billing of $140,778. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Palo Alto, CA
- Active Since 10/12/2007
- Last Updated 04/23/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407044639
Products in Payments
- XARELTO (Drug) $38,230
- SOTAGLIFLOZIN (Drug) $4,450
- INVOKANA (Drug) $3,273
- CHANTIX (Drug) $72.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Palo Alto
Eunjeong Kim
Cardiovascular Disease — Payments: $57,365
Dr. Richard Popp, M.d, M.D
Cardiovascular Disease — Payments: $33,150
Eri Fukaya, Md, MD
Cardiovascular Disease — Payments: $27,758
Shaun Cho, Md, MD
Cardiovascular Disease — Payments: $24,077
Dr. John Giacomini, Md, MD
Cardiovascular Disease — Payments: $14,558
Abhinav Sharma
Cardiovascular Disease — Payments: $12,889